What is the recommended dosing for Polyethylene Glycol (PEG) in treating constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Polyethylene Glycol (PEG) in Treating Constipation

The recommended dosing for Polyethylene Glycol (PEG) in treating constipation is 17 g once daily mixed in 4-8 ounces of liquid, with demonstrated efficacy for up to 6-12 months of continuous use. 1, 2

Standard Dosing Recommendations

  • For adults and children 17 years of age and older, the FDA-approved dose is 17 g of PEG 3350 once daily mixed in 4-8 ounces of any beverage (cold, hot, or room temperature) 2
  • The American Gastroenterological Association strongly recommends PEG compared with management without PEG for chronic idiopathic constipation (CIC) based on moderate certainty of evidence 3
  • PEG should be fully dissolved in liquid before drinking and should not be combined with starch-based thickeners used for difficult swallowing 2
  • For over-the-counter use, PEG 3350 should not be used for more than 7 days without consulting a doctor 2

Dosing Based on Formulation

  • PEG 3350 without electrolytes: 17 g once daily mixed in 8 ounces of liquid 3, 1
  • PEG with electrolytes: 17.5 g twice daily dissolved in 250 mL of water (based on clinical trials) 3
  • For severe constipation or fecal impaction, higher doses may be required - up to 68 g has been shown to be effective and safe for rapid relief within 24 hours 4, 5

Duration of Treatment

  • Response to PEG has been shown to be durable over 6 months in controlled clinical trials 3, 6
  • Long-term safety studies have demonstrated PEG to be safe and effective for treating constipation for up to 12 months, with no evidence of tachyphylaxis 7
  • For chronic idiopathic constipation, extended use beyond the FDA-approved 7-day limit may be appropriate under medical supervision 1, 7

Efficacy and Response

  • PEG significantly increases complete spontaneous bowel movements (CSBMs) per week compared to placebo (MD 2.90, CI 2.12–3.68) 3
  • PEG also increases spontaneous bowel movements (SBMs) per week (MD 2.30, CI 1.55–3.06) 3
  • Response rates are high, with studies showing 52% of PEG users achieving treatment success compared to only 11% with placebo 6
  • Efficacy is maintained in elderly patients, with 84-94% reporting successful treatment 7

Side Effects and Safety Considerations

  • Common side effects include abdominal distension, loose stool, flatulence, and nausea 3, 1
  • Diarrhea is more common with PEG than placebo (158 more per 1,000 patients) but is generally mild to moderate in severity 3, 1
  • Long-term studies show no clinically significant changes in hematology or blood chemistry, particularly electrolytes, even with extended use 7
  • PEG is contraindicated in patients with known or suspected gastrointestinal obstruction 5

Implementation Tips

  • A trial of fiber supplement can be considered for mild constipation before PEG use or in combination with PEG 3
  • For children 16 years of age or under, consult a doctor before using PEG 2
  • For optimal results, ensure the PEG powder is completely dissolved before drinking 2
  • PEG is widely available without prescription and is relatively inexpensive, making it appropriate for early use in constipation management 3

References

Guideline

Polyethylene Glycol 3350 Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Overnight efficacy of polyethylene glycol laxative.

The American journal of gastroenterology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.